AI-powered drug development

1 articles
The Motley FoolThe Motley Fool··Prosper Junior Bakiny

Pharma Giant and Cloud Pioneer Lead Growth Stock Rally Into 2026

Analysts spotlight $LLY's obesity drug dominance and $VEEV's cloud expansion as top growth picks for first half 2026.
LLYVEEVlong-term investingGLP-1 drugs